Identification of metastatic papillary thyroid carcinoma in FNA specimens using thyroid peroxidase immunohistochemistry

被引:9
|
作者
Shield, P. W. [1 ,2 ]
Crouch, S. J. [3 ]
Papadimos, D. J. [1 ,3 ]
Walsh, M. D. [3 ]
机构
[1] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld, Australia
[2] Sullivan Nicolaides Pathol, Cytol Dept, Brisbane, Qld, Australia
[3] Sullivan Nicolaides Pathol, Histopathol Dept, Brisbane, Qld, Australia
关键词
cytology; fine needle aspiration; immunohistochemistry; metastatic; thyroid papillary carcinoma; thyroid peroxidase; FINE-NEEDLE-ASPIRATION; TRANSCRIPTION FACTOR-I; LYMPH-NODE METASTASES; DIFFERENTIAL-DIAGNOSIS; THYROGLOBULIN; CANCER; CYTOLOGY; TUMORS; GALECTIN-3; PITFALL;
D O I
10.1111/cyt.12531
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
IntroductionWe evaluated immunohistochemical staining for thyroid peroxidase (TPO), a glycoprotein found in the apical plasma membrane of thyroid follicular cells, as a marker for metastatic PTC in FNA samples and compared results with thyroglobulin (Tg) and thyroid transcription factor 1 (TTF1) staining. MethodsCell block sections prepared from 100 FNA specimens were stained with a rabbit monoclonal antibody to TPO (EP159). The FNAs included 64 metastatic malignancies from non-thyroid primary sites, including 18 lung, and 36 cases of thyroid tumours (29 PTC, six cases of medullary thyroid carcinoma and one thyroid anaplastic carcinoma). Thyroid tumours were stained with TTF1 and Tg in addition to TPO. All cases of metastatic lung carcinoma also had TTF-1 staining results. ResultsTPO staining was negative in all non-thyroid malignancies. Ninety percent (26/29) of PTC were positive. All positive cases showed strong cytoplasmic staining, although 54% (14/26) showed positivity in less than half of the cells. By comparison, Tg staining of TPC cases was present in 62% and TTF-1 in 100%. In addition to showing higher sensitivity, interpretation of staining results with TPO was generally easier with than Tg. All metastatic lung adenocarcinomas were positive for TTF-1 and TPO negative. The six medullary cancers showed positivity in 17%, 0% and 83% with TPO, Tg and TTF-1, respectively. ConclusionsTPO (mAb EP159) may be a useful addition to immunohistochemical panels for FNA specimens where metastatic PTC is a consideration, particularly in cases where metastatic lung carcinoma features in the differential diagnosis. Ninety percent of metastatic papillary thyroid carcinomas in cell block specimens from lymph node aspirates were positive for thyroid peroxidase. This was more sensitive than thyroglobulin and more specific than TTF-1, which also stained all metastatic lung adenocarcinomas.
引用
收藏
页码:227 / 232
页数:6
相关论文
共 50 条
  • [1] The influence of thyroid status, serum Tg, TSH, and TgAb on FNA-Tg in cervical metastatic lymph nodes of papillary thyroid carcinoma
    Sun, Jingjing
    Li, Peipei
    Chen, Xiao
    Yu, Qiujie
    Li, Li
    LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2022, 7 (01): : 274 - 282
  • [2] Follicular Variant of Papillary Thyroid Carcinoma: Accuracy of FNA Diagnosis and Implications for Patient Management
    Ustun, Berrin
    Chhieng, David
    Prasad, Manju L.
    Holt, Elizabeth
    Hammers, Lynwood
    Carling, Tobias
    Udelsman, Robert
    Adeniran, Adebowale J.
    ENDOCRINE PATHOLOGY, 2014, 25 (03) : 257 - 264
  • [3] Papillary thyroid carcinoma metastatic to the pancreas: Case report
    Cho, Margaret
    Acosta-Gonzalez, Gabriel
    Brandler, Tamar C.
    Basu, Atreyee
    Wei, Xiao-Jun
    Simms, Anthony
    DIAGNOSTIC CYTOPATHOLOGY, 2019, 47 (03) : 214 - 217
  • [4] Cytological Characteristics of Papillary Thyroid Carcinoma on LBC Specimens, Compared with Conventional Specimens
    Suzuki, Ayana
    Hirokawa, Mitsuyoshi
    Higuchi, Miyoko
    Yamao, Naoki
    Kuma, Seiji
    Nakamura, Hirotoshi
    Amino, Nobuyuki
    Miyauchi, Akira
    DIAGNOSTIC CYTOPATHOLOGY, 2015, 43 (02) : 108 - 113
  • [5] Influence of presence/absence of thyroid gland on the cutoff value for thyroglobulin in lymph-node aspiration to detect metastatic papillary thyroid carcinoma
    Zhao, Huan
    Wang, Yong
    Wang, Min-jie
    Zhang, Zhi-hui
    Wang, Hai-rui
    Zhang, Bing
    Guo, Hui-qin
    BMC CANCER, 2017, 17
  • [6] Use of BRAF V600E Immunocytochemistry on FNA Direct Smears of Papillary Thyroid Carcinoma
    Wobker, Sara E.
    Kim, Lawrence T.
    Hackman, Trevor G.
    Dodd, Leslie G.
    CANCER CYTOPATHOLOGY, 2015, 123 (09) : 531 - 539
  • [7] Availability of Immunohistochemistry in the Diagnosis of Follicular Variant of Papillary Thyroid Carcinoma
    Jeong, Ji Yun
    Jang, Jung Sik
    Sohn, Yoon Kyung
    Jung, Jin Hyang
    Chun, Yi Kyeong
    Park, Ji Young
    KOREAN JOURNAL OF PATHOLOGY, 2010, 44 (01) : 48 - 55
  • [8] Evaluation of the VE1 Antibody in Thyroid Cytology Using Ex Vivo Papillary Thyroid Carcinoma Specimens
    Kim, Yon Hee
    Yim, Hyunee
    Lee, Yong-Hee
    Han, Jae Ho
    Lee, Kyi Beom
    Lee, Jeonghun
    Soh, Euy Young
    Jeong, Seon-Yong
    Kim, Jang-Hee
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2016, 50 (01) : 58 - 66
  • [9] TROP-2 expression in papillary thyroid carcinoma: Potential Diagnostic Utility
    Simms, Anthony
    Jacob, Reuben P.
    Cohen, Cynthia
    Siddiqui, Momin T.
    DIAGNOSTIC CYTOPATHOLOGY, 2016, 44 (01) : 26 - 31
  • [10] Papillary Thyroid Carcinoma and Variants
    Auger, Manon
    Stelow, Edward B.
    Yang, Grace C. H.
    Sanchez, Miguel A.
    Asa, Sylvia L.
    Livolsi, Virginia A.
    BETHESDA SYSTEM FOR REPORTING THYROID CYTOPATHOLOGY: DEFINITIONS, CRITERIA AND EXPLANATORY NOTES, 2010, : 91 - +